[Vascular Calcification - Pathological Mechanism and Clinical Application - . The effect of phosphate binders on...

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Pharmacology

Background:

• Vascular calcification is a significant complication in chronic kidney disease-mineral bone disorder (CKD-MBD), directly impacting cardiovascular prognosis.
• Phosphate binders (PB) are crucial for managing hyperphosphatemia, a condition linked to vascular calcification.
• Available PBs include calcium (Ca)-based and non-Ca-based types, each with distinct implications for calcification.

Purpose of the Study:

• To review the role of different phosphate binders in managing vascular calcification within the context of CKD-MBD.
• To compare the efficacy and safety profiles of calcium-based versus non-calcium-based phosphate binders regarding vascular calcification.
• To highlight considerations for selecting appropriate phosphate binders, particularly in the Japanese healthcare setting.

Main Methods:

• Literature review of studies on phosphate binders and vascular calcification in CKD-MBD.
• Analysis of clinical data comparing calcium-based and non-calcium-based phosphate binders.
• Consideration of emerging non-Ca-based binders (e.g., iron, magnesium) and their potential impact.

Main Results:

• Non-Ca-based phosphate binders have demonstrated potential in retarding vascular calcification progression.
• Calcium-based phosphate binders raise concerns regarding potential calcium overload and promotion of calcification.
• Newer non-Ca-based options, including iron and magnesium formulations, are emerging.

Conclusions:

• Selection of phosphate binders for CKD-MBD patients requires careful consideration of vascular calcification risks.
• Non-calcium-based binders appear more favorable for mitigating vascular calcification compared to calcium-based ones.
• Factors such as cost, pill burden, and patient-specific circumstances, especially in Japan, are critical for optimal PB selection.